ANTI-FAS ON NONHEMATOPOIETIC TUMORS - LEVELS OF FAS/APO-1 AND BCL-2 ARE NOT PREDICTIVE OF BIOLOGICAL RESPONSIVENESS

被引:0
|
作者
OWENSCHAUB, LB
RADINSKY, R
KRUZEL, E
BERRY, K
YONEHARA, S
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CELL BIOL,HOUSTON,TX 77030
[2] JAPAN TOBACCO INC,PHARMACEUT BASIC RES LABS,YOKOHAMA 236,JAPAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fas/APO-1 is a cell surface protein known to trigger apoptosis in a variety of cell types upon specific antibody binding. Although extensively studied on normal and malignant hematopoietic cells, little is known about Fas/APO-1 on nonhematopoietic cells. In the study presented here, we have examined Fas/APO-1 expression and function on 11 human tumors of nonhematopoietic origin. By dow cytometric analysis, Fas/APO-1 was expressed on 10 of the 11 tumors at levels comparable to those previously reported for lymphoid cells sensitive to the cytolytic effects of anti-Fas. Despite abundant cell surface expression, only 4 of the 10 Fas-positive tumors were sensitive to the cell-killing effects of anti-Fas. Moreover, anti-Fas enhanced the growth of 2 of 10 Fas-positive tumors. Additional studies using cycloheximide demonstrated that de novo protein synthesis was required for anti-Fas-triggered growth stimulation and, at least in one case, was responsible for the resistance to antibody-induced apoptosis. The biological effects initiated by anti-Fas engagement, however were not correlated with endogenous bcl-2 expression. This report documents that: (a) Fas/APO-1 is widely expressed on cultured nonhematopoietic tumors; (b) the inherent susceptibility to anti-Fas-induced apoptosis is not correlated with expression of the Fas/APO-1 protein; (c) Fas/APO-1 engagement can result in growth enhancement; and (d) protective/growth-promoting proteins other than bcl-2 may contribute to the diverse spectrum of biological effects induced by anti-Fas engagement of the Fas/APO-1 protein.
引用
收藏
页码:1580 / 1586
页数:7
相关论文
共 50 条
  • [31] Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis
    Wetzig, T
    Petri, JB
    Mittag, M
    Haustein, UF
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1998, 290 (04) : 187 - 190
  • [32] Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
    Koomägi, R
    Volm, M
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (03) : 239 - 243
  • [33] Decrease of glutathione in Fanconi anemia group C cells during apoptosis induced by anti-Fas/APO-1 antibody.
    Fabian, I
    Pearl, M
    Halperin, D
    BLOOD, 2001, 98 (11) : 557A - 558A
  • [34] Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis
    T. Wetzig
    J. B. Petri
    M. Mittag
    U.-F. Haustein
    Archives of Dermatological Research, 1998, 290 : 187 - 190
  • [35] Expression of Fas (APO-1/CD95) and Fas ligand in astrocytic brain tumors and the mechanisms of necrogenesis in glioblastomas
    Ohgaki, H
    Gratas, C
    Tohma, Y
    Tachibana, O
    Kleihues, P
    BRAIN PATHOLOGY, 1997, 7 (04) : 1183 - 1183
  • [36] Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study)
    Demir, G
    Ozguroglu, M
    Sayhan, N
    Molinas-Mandel, N
    Demirelli, F
    Buyukunal, E
    Tuzuner, N
    Serdengecti, S
    Berkarda, B
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3517 - 3520
  • [37] Elevated serum soluble Fas/Apo-1 levels in collagen diseases and silicosis.
    Aikoh, T
    Tomokuni, A
    Ueki, A
    Ueki, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 664 - 664
  • [38] ANTI-FAS APO-1 ANTIBODY-MEDIATED APOPTOSIS OF CULTURED HUMAN GLIOMA-CELLS - INDUCTION AND MODULATION OF SENSITIVITY BY CYTOKINES
    WELLER, M
    FREI, K
    GROSCURTH, P
    KRAMMER, PH
    YONEKAWA, Y
    FONTANA, A
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03): : 954 - 964
  • [39] Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection
    Silvestris, F
    Grinello, D
    Del Prete, A
    Cafforio, P
    Quarto, M
    Dammacco, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (07) : 603 - 614
  • [40] Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, bcl-2 or bcl-x transduction
    H Elizabeth Broome
    Catherine M Dargan
    Thomas Brunner
    Douglas R Green
    Cell Death & Differentiation, 1998, 5 : 200 - 205